Universal Navigation

Join or Renew Your Membership Join Now

S16 - Huntington's Disease: From Bench to Clinical Trials

Event Time:	Monday May 6, 2019 1:00 pm to 3:00 pm
Topic(s):	Movement Disorders
Director(s):
Description:
Completion Message:
CME Credits:	2
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
2:40 PM - 3:00 PM	Q&A Panel with Authors	Faculty

Disclosures
Speaker	Disclosure

Abstract Presenters
Start Time	Pub.	Title	Presenter
1:00 PM	003	Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease	Filipe Brogueira Rodrigues Disclosure: Dr. Brogueira Rodrigues has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GLG.
1:00 PM	004	Understanding HD Psychosis: An Analysis from the ENROLL-HD Database	Disclosure: Dr. Jaini has nothing to disclose.
1:00 PM	005	Translational Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling Strategy to Support RG6042 Dose Selection in Huntington’s Disease (HD)	Disclosure: Dr. Sanwald Ducray has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with F.Hoffmann-La Roche Ltd..
1:00 PM	006	The Biodistribution and Tolerability of rAAV5-miHTT after Bilateral Intra-striatal Delivery to Non-human Primates	Disclosure: Dr. de Haan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with uniQure, Inc. Dr. de Haan has received research support from uniQure, Inc.
1:00 PM	007	The Efficacy and Safety Results of Laquinimod as a Treatment for Huntington Disease (LEGATO-HD)	Disclosure: Dr. Reilmann has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion Pharmaceuticals, AOP Orphan Pharmaceuticals, CHDI Foundation, Desitin, Hoffmann-LaRoche, Ipsen, Ionis Pharmaceuticals, Mitoconix, Neurosearch, Novartis, Pfizer, Prana Biotechnology, Raptor Pharmaceuticals, Temmler Pharma GmbHT, Teva, UniQure, UniQure, Huntington Study Group, European Huntington Disease Network. Dr. Reilmann has received research support from Teva Pharmaceuticals, Amarin Neuroscience, AOP Orphan Pharmaceuticals, CHDI Foundation, Hoffmann-LaRoche, Ipsen, Neurosearch, Novartis, Pfizer, Siena Biotech, UniQure, European Huntington Disease Network, Bundesministerium Bildung und Forschung (BMBF), Cure Huntington Disease Initiative Foundation, Deutsche Forschungsgemeinschaft, Deutsches Zentrum Neurodegeneration und Entzndung (DZNE), European Union 7th Framework Program (EU-FP7).
1:00 PM	008	Preliminary Report on the Safety and Tolerability of Bone marrow-derived Allogeneic Mesenchymal Stem Cells infused intravenously in Parkinson’s disease Patients	Disclosure: Dr. Schiess has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Medtronic. Dr. Schiess has received research support from Medtronic.
1:00 PM	009	Innovative Recruitment Strategies Increase Diversity of Participation in the Fox Insight Longitudinal Cohort	Disclosure: Dr. Dobkin has nothing to disclose.

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Saturday, May 4, 2019
7:00 AM-9:00 AM
C6 - Therapy of Movement Disorders: A Case-based Approach David Riley MD
9:30 AM-11:30 AM
C18 - Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
1:30 PM-3:30 PM
C34 - Evaluating Tremor in the Office Andres Deik Acosta Madiedo MD
2:30 PM-3:15 PM
Dancing with Parkinson's Diviya Kaul MD
4:15 PM-5:30 PM
Hot Topics Plenary Session Eric Klawiter MD, FAAN

Sunday, May 5, 2019
7:00 AM-9:00 AM
C42 - The Dystonias: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
11:30 AM-6:30 PM
P1 - Poster Session 1
1:00 PM-3:00 PM
C51 - Balance and Gait Disorders Alfonso Fasano MD, PhD
S4 - Clinical Trials in Movement Disorders
3:30 PM-5:30 PM
C67 - Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology Ralph Jozefowicz MD, FAAN, Adam Quick MD
C72 - Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease LynnMarie Trotti MD
N1 - Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN
S10 - Biomarkers in Movement Disorders

Monday, May 6, 2019
7:00 AM-9:00 AM
C83 - Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN
C87 - Skills Workshop: Clinical Usefulness of Botulinum Toxin for Spasticity (Registration Required) Allison Brashear MD, MBA, FAAN
11:30 AM-6:30 PM
P2 - Poster Session 2
1:00 PM-3:00 PM
C93 - Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
1:00 PM-5:30 PM
C105 - Skills Workshop: Clinical Uses of Botulinum Toxin for Dystonia (Registration Required) Diego Torres-Russotto MD, FAAN
3:30 PM-5:30 PM
C117 - Tourette Syndrome: Assessment and Management Tamara Pringsheim MD, FAAN
5:00 PM-5:45 PM
Careers in Movement Disorders Stanley Fahn MD, FAAN

Tuesday, May 7, 2019
7:00 AM-9:00 AM
C127 - Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
11:30 AM-6:30 PM
P3 - Poster Session 3
1:00 PM-3:00 PM
C137 - Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Michael Pourfar MD
3:30 PM-5:30 PM
C155 - Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Leonard Verhagen Metman MD, PhD
IS2 - Invited Science: Movement Disorders Deborah Hall MD, PhD, FAAN

Wednesday, May 8, 2019
7:00 AM-9:00 AM
C168 - Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
C170 - Video EEG: Name That Spell Amy Crepeau MD
8:00 AM-8:45 AM
Complementary Therapies in Parkinson's Disease Veronica Santini MD, MA
11:30 AM-6:30 PM
P4 - Poster Session 4
1:00 PM-1:45 PM
Understanding the AAN's Latest Guidelines Tamara Pringsheim MD, FAAN
1:00 PM-3:00 PM
C179 - Nonmotor Manifestations of Parkinson's Disease I Jennifer Goldman MD, MS, FAAN
C185 - Actualización en trastornos del movimiento (Update in Movement Disorders) Andres Deik Acosta Madiedo MD
3:30 PM-5:30 PM
C196 - Nonmotor Manifestations of Parkinson's Disease II Jennifer Goldman MD, MS, FAAN
N5 - Neuroscience in the Clinic: Wearable Technology Deborah Hall MD, PhD, FAAN, Eric Klawiter MD, FAAN
S41 - Imaging in Movement Disorders

Thursday, May 9, 2019
7:00 AM-9:00 AM
C209 - Movement Disorders for the General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson's Disease Irene Litvan MD, FAAN
11:30 AM-6:30 PM
P5 - Poster Session 5
1:00 PM-3:00 PM
C220 - Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia Joohi Jimenez Shahed MD
3:30 PM-5:30 PM
C233 - Therapy in Neurology IV: Movement Disorders and Stroke David Dodick MD, FAAN
C234 - Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics Shyamal Mehta MD, PhD
S53 - Movement Disorders: Genetics and Clinical Features
7:00 PM-10:00 PM
C240 - Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN

Friday, May 10, 2019
7:00 AM-9:00 AM
C246 - Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
1:00 PM-3:00 PM
C253 - Update in Movement Disorders Alfonso Fasano MD, PhD

Footer